News

Promising, new data from a clinical trial of Bellerophon Therapeutics’ product candidate developed under the INOpulse® program targeting pulmonary hypertension was recently presented at the European Respiratory Society (ERS) International Congress 2015. The results could eventually lead to an approved therapy for Pulmonary Hypertension associated with COPD. Pulmonary hypertension is characterized by…

North Bergen, New Jersey locals Carlos Torres and Martha Gonzalez reported in a recent press release that they felt “extremely blessed” upon witnessing Pope Francis kiss their 9-year-old son, Daniel, during His Holiness’ New York City visit, believing that the Pope’s blessing may help Daniel fight…

A recent study from Japan has shown that dividing cells involved in causing idiopathic pulmonary arterial hypertension (IPAH) may be stopped with a new type of drug called a calcilytic. The research could led to new treatments for IPAH. The study, titled “Inhibition of Excessive Cell Proliferation…

An international group of scientists has comprehensively characterized the genetics of pulmonary arterial hypertension (PAH). This new information could ultimately help clinicians treat the disease based on individual traits and genetic makeup. This is the most complete set of genetic data that has been collected about the disease to date.

Bellerophon Therapeutics recently announced that INOpulse, a type of nitric oxide that helps blood vessels expand, is effective in treating Pulmonary Arterial Hypertension (PAH) based on middle-stage data from a Phase 2 trial. The US Food and Drug Administration (FDA) has issued a Special Protocol Assessment (SPA), which will help to…

Actelion Pharmaceuticals, a biopharmaceutical company developing pulmonary arterial hypertension (PAH) therapies, recently announced the presentation of further data from its pivotal Phase III GRIPHON study testing investigational PAH treatment selexipag (Uptravi) during the 2015 European Respiratory Society (ERS) Congress, which will take place in Amsterdam, Netherlands. The presentation is titled…

Brooklyn Brazilian Jiu-Jitsu, the city’s leading consortium of martial arts schools across Bensonhurst, Cobble Hill, Clinton Hill, Dyker Heights and Gravesend, is showing its commitment to supporting charities by pledging funds raised all throughout last month to the Pulmonary Hypertension Association to help fund patient services and urgent research programs geared…

According to an article entitled “Mosaic Pattern of Lung Attenuation on Chest CT in Patients with Pulmonary Hypertension”  published in the journal Disease on September 7, 2015 and authored by Kamonpun Ussavarungsi et al., a mosaic lung attenuation pattern can be observed in the chest…

In a recent collaborative research project published in the PLOS one journal entitled “Risk Factors of Pulmonary Hypertension in Brazilian Patients with Sickle Cell Anemia,” researchers suggest that patients suffering from sickle cell anemia (SCA) have higher risks for developing pulmonary hypertension (PH). Sickle-cell…

The Pulmonary Hypertension Association (PHA) is currently hosting the 2015 PH Professional Network (PHPN) Symposium, which began on Thursday, September 17 and will run until Saturday, September 19 at the Crystal Gateway Marriott in Arlington, Va. Invited to give an inspiring and insightful talk on her story as a PH patient is Pam Kehoe,…

Reata Pharmaceuticals has announced that it will present Phase 2 results from a trial of its investigational therapy bardoxolone methyl in treating pulmonary arterial hypertension (PAH). The study’s findings will be presented October 27, 2015 at the 2015 American College of Chest Physicians (CHEST) annual meeting in Montreal, Canada in a…

Cytori Therapeutics recently published a report of 12-month data from the Scleradec-I clinical trial studying hand dysfunction in people with scleroderma. Findings from the 12 patient trial, which was led by Dr. Brigitte Granel and Dr. Guy Magalon of the Assistance Publique des Hôpitaux de Marseille in France, is titled “Autologous…